R. Gloeckl (Schoenau am Koenigssee, Germany), Z. Bingol (Istanbul, Turkey)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Late Breaking Abstract - Effects of pulmonary rehabilitation on major symptoms of long COVID (post-COVID-19 syndrome): preliminary results
F. Alexandre (Lodeve, France), A. Castanyer (Ossèja, France), A. Vernet (Ossèja, France), J. Aliaga-Parera (Ossèja, France), N. Oliver (Lodeve, France), V. Molinier (Lodeve, France), N. Héraud (Lodeve, France), F. Alexandre (Lodeve, France)
|   |
Levels of functioning in asthma patients using the WHODAS II
N. Sanina (Dnipro, Ukraine), A. Ipatov (Dnipro, Ukraine), N. Hondulenko (Dnipro, Ukraine), S. Panina (Dnipro, Ukraine)
| |
Early Supported Discharge with Home Oxygen in COVID-19 Patients
M. Pittman (Essex, United Kingdom), M. Boa (Essex, United Kingdom), J. Feaver (Essex, United Kingdom), K. Young (Essex, United Kingdom), A. Ncube (Essex, United Kingdom), O. Jallow (Essex, United Kingdom), J. Kohn (Essex, United Kingdom), J. Peacock (Essex, United Kingdom)
| |
Pulmonary rehabilitation and changes in respiratory muscles, aerobic capacity and quality of life in Colombian patients with Interstitial Lung Disease
L. Orozco Mejía (Cali, Colombia), A. López López (Manizales, Colombia), R. Mosquera (Cali, Colombia), J. Rivera Motta (Cali, Colombia)
| |
Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features
O. Shchudro (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine), L. Konopkina (Dniepropetrovsk, Ukraine)
| |
Patients’ and caregivers’ perceptions toward nebulization therapy for COPD: The first quantitative survey done in India
H. Dumra (Ahmedabad, India), A. Khanna (Kaushambi, India), S. Madhukar (Kankarbagh, India), M. Lopez (Mumbai, India), R. Hegde (Mumbai, India), J. Gogtay (Mumbai, India), D. More (Mumbai, India)
| |
Desaturation-distance ratio during field exercise test in lymphangioleiomyomatosis: a cross-sectional study
D. Silva Queiroz (São Paulo , Brazil), C. Cristine Berto Marques Da Silva (São Paulo , Brazil), A. Franco Amaral (São Paulo , Brazil), M. Rodrigues Oliveira (São Paulo , Brazil), H. Takachi Moriya (São Paulo , Brazil), C. R R Carvalho (São Paulo , Brazil), B. Guedes Baldi (São Paulo , Brazil), C. R F Carvalho1 (São Paulo , Brazil)
| |
Covid-19 related concerns and outcomes from shielding in clinically extremely vulnerable adults and children with neuromuscular disease
L. Spurr (London, United Kingdom), R. Wakeman (London, United Kingdom), H. Tan (London, United Kingdom), M. Chatwin (London, United Kingdom), A. Simonds (London, United Kingdom)
| |
Development of Culturally Appropriate Pulmonary Rehabilitation (PR) for Sri Lanka: A qualitative study
C. Perera (Kelaniya, Sri Lanka), Z. Yusuf (Leicester, United Kingdom), A. Jayamaha (Colombo, Sri Lanka), M. Orme (Leicester, United Kingdom), U. Wijayasiri (Colombo, Sri Lanka), T. Amarasekara (Colombo, Sri Lanka), A. Jones (Leicester, United Kingdom), R. Miah (Leicester, United Kingdom), R. Jones (Plymouth, United Kingdom), A. Barton (Leicester, United Kingdom), M. Stainer (Leicester, United Kingdom), S. Wimalasekara (Colombo, Sri Lanka), S. Singh (Leicester, United Kingdom)
| |
Factors affecting caregiver burden in pulmonary patients
B. Yilmaz Kara (Rize, Turkey)
| |
The role of personality traits in the pulmonary rehabilitation response in COPD patients
P. Caille (Montpellier, France), F. Alexandre (Lodève, France), V. Molinier (Lodève, France), N. Héraud (Lodève, France)
| |
Validity and reliability evidence of the general self-efficacy scale in Greek patients with COPD.
A. Daskalakis (Athens, Greece), V. Brisimis (Athens, Greece), E. Grammatopoulou (Athens, Greece), E. Smyrli (Athens, Greece), A. Chaniotou (Athens, Greece)
| |
Effectiveness of triage pathways for prioritising patient care by a multi-disciplinary community respiratory team during the COVID-19 pandemic
E. Turner (Glasgow, United Kingdom), E. Johnson (Glasgow, United Kingdom), S. Gingles (Glasgow, United Kingdom), K. Levin (Glasgow, United Kingdom), E. Mackay (Glasgow, United Kingdom), C. Roux (Glasgow, United Kingdom), K. Farrell (Glasgow, United Kingdom), M. Milligan (Glasgow, United Kingdom), K. Murray (Glasgow, United Kingdom), S. Adams (Glasgow, United Kingdom), M. Mackie (Glasgow, United Kingdom), J. Brand (Glasgow, United Kingdom), H. Bayes (Glasgow, United Kingdom), D. Anderson (Glasgow, United Kingdom)
| |
Frequency of dyspnea in patients with post-COVID syndrome
F. Diaferia (bari, Italy), A. Portacci (bari, Italy), E. Lulaj (bari, Italy), M. Fucci (bari, Italy), E. Spalluto (bari, Italy), S. Dragonieri (bari, Italy), G. Carpagnano (bari, Italy)
| |
Frailty: An indicator for poor outcomes among in-hospital pulmonology patients
N. Acet Öztürk (Bursa, Turkey), A. Görek Dilektasli (Bursa, Turkey), Ö. Aydin Güçlü (Bursa, Turkey), A. Ursavas (Bursa, Turkey), E. Demirdögen (Bursa, Turkey), F. Coskun (Bursa, Turkey), E. Uzaslan (Bursa, Turkey), M. Karadag (Bursa, Turkey)
| |
Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
A. Calvache Mateo (Granada, Spain), L. López López (Granada, Spain), J. Rodríguez Torres (Granada, Spain), I. Torres Sáncehz (Granada, Spain), M. Granados Santiago (Granada, Spain), J. Martín Núñez (Granada, Spain), M. Valenza (Granada, Spain)
| |
Does a supplementation in branch amino acid improve pulmonary rehabilitation effect in COPD?
J. Meurice (Poitiers, France), F. Caron (Poitiers, France), P. Ingrand (Poitiers, France), Q. Bretonneau (Poitiers, France), O. Dupuy (Poitiers, France), C. De Bisschop (Poitiers, France)
| |
Effects of Combined Physical Training on Lung Function and Mechanics and on Pulmonary Immune Response in Overweight and Obese Women
A. Silva-Reis (Santos, Brazil), M. A Rodrigues Brandao-Rangel (Santos, Brazil), R. Moraes-Ferreira (Santos, Brazil), T. G Gonçalves-Alves (Santos, Brazil), V. H Souza-Palmeira (Santos, Brazil), H. C Aquino-Santos (Santos, Brazil), C. R Frison (Santos, Brazil), R. P Vieira (Santos, Brazil)
| |
Late Breaking Abstract - Functional benefits of post COVID-19 multidisciplinary pulmonary rehabilitation program
R. Haouchan (Beirut, Lebanon), M. Riachy (Beirut, Lebanon), C. Harmouche (Beirut, Lebanon), Z. Naoum (Beirut, Lebanon), M. Salameh (Beirut, Lebanon), P. Merheb (Beirut, Lebanon), T. Matta (Beirut, Lebanon), S. Aoun (Beirut, Lebanon), A. Kik (Beirut, Lebanon), M. Raad (Beirut, Lebanon), H. Eid (Beirut, Lebanon), B. Habr (Beirut, Lebanon)
| |
Process evaluation of the British Lung Foundation Active Steps service
A. Jones (Melbourne, Australia), H. Robinson (Lincoln, United Kingdom), M. Saunders (Lincoln, United Kingdom), A. Brewster (Lincoln, United Kingdom), C. Ridyard (Lincoln, United Kingdom), M. Smith (Lincoln, United Kingdom), J. Peel (London, United Kingdom), J. Shopland (London, United Kingdom), C. Wilson (London, United Kingdom), J. Swan (London, United Kingdom), S. Frizzell (London, United Kingdom), A. Dean (London, United Kingdom), M. Hinchliffe (London, United Kingdom), G. Law (Lincoln, United Kingdom), N. Siriwardena (Lincoln, United Kingdom)
| |